1. Home
  2. MTSI vs INM Comparison

MTSI vs INM Comparison

Compare MTSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • INM
  • Stock Information
  • Founded
  • MTSI 1950
  • INM 1981
  • Country
  • MTSI United States
  • INM Canada
  • Employees
  • MTSI N/A
  • INM N/A
  • Industry
  • MTSI Semiconductors
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTSI Technology
  • INM Health Care
  • Exchange
  • MTSI Nasdaq
  • INM Nasdaq
  • Market Cap
  • MTSI N/A
  • INM 3.4M
  • IPO Year
  • MTSI 2012
  • INM N/A
  • Fundamental
  • Price
  • MTSI $136.21
  • INM $4.08
  • Analyst Decision
  • MTSI Strong Buy
  • INM
  • Analyst Count
  • MTSI 10
  • INM 0
  • Target Price
  • MTSI $128.00
  • INM N/A
  • AVG Volume (30 Days)
  • MTSI 594.4K
  • INM 22.8K
  • Earning Date
  • MTSI 01-30-2025
  • INM 02-11-2025
  • Dividend Yield
  • MTSI N/A
  • INM N/A
  • EPS Growth
  • MTSI N/A
  • INM N/A
  • EPS
  • MTSI 1.04
  • INM N/A
  • Revenue
  • MTSI $729,578,000.00
  • INM $4,960,506.00
  • Revenue This Year
  • MTSI $26.74
  • INM N/A
  • Revenue Next Year
  • MTSI $10.96
  • INM N/A
  • P/E Ratio
  • MTSI $130.97
  • INM N/A
  • Revenue Growth
  • MTSI 12.52
  • INM 5.17
  • 52 Week Low
  • MTSI $79.25
  • INM $2.42
  • 52 Week High
  • MTSI $143.90
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 53.32
  • INM 37.19
  • Support Level
  • MTSI $129.35
  • INM $4.11
  • Resistance Level
  • MTSI $141.89
  • INM $5.41
  • Average True Range (ATR)
  • MTSI 3.82
  • INM 0.34
  • MACD
  • MTSI -0.34
  • INM -0.07
  • Stochastic Oscillator
  • MTSI 57.03
  • INM 6.99

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: